Skip to main content
. Author manuscript; available in PMC: 2012 Mar 1.
Published in final edited form as: Angiogenesis. 2010 Dec 28;14(1):61–68. doi: 10.1007/s10456-010-9195-8

Fig. 1.

Fig. 1

Effect of VEGI treatment on the growth and vascularization of LLC tumors a Average tumor size in mice treated with either vehicle (Control, n = 6) or VEGI (n = 6) given by intraperitoneal injection. b Box plot showing average intensities of CD31 immunostaining scored on Day 7 LLC tumor samples on a scale of 1–4, with 4 being the most